Advanced Oncotherapy Investor Relations Material

Advanced Oncotherapy PLC is a UK-based company that specializes in the development and provision of proton therapy systems for cancer treatment, notably their proprietary system known as LIGHT (Linac Image Guided Hadron Technology). This innovative technology, a product of over 25 years of work at CERN and ADAM, aims to revolutionize proton therapy by enhancing the precision and effectiveness of cancer treatments. The LIGHT system's compact configuration and linear design allow for greater precision and electronic control during treatment, offering the potential for more tailored and effective cancer therapy options. The company is committed to making proton therapy more accessible and affordable, with a focus on maximizing the therapeutic effect of radiation on tumors while minimizing damage to healthy tissue. The company is headquartered in London, United Kingdom, and its shares are listed on the London Stock Exchange.